Is Ajooni Biotech Ltd debt-free?

Yes, Ajooni Biotech Ltd is debt-free with a debt-to-equity ratio of 0.02.

Home

Ajooni Biotech Ltd

Ajooni Biotech Ltd Financials

Ajooni Biotech Ltd Financial Statement

Ajooni Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2025	Jun 2025	Mar 2025
Revenue	31.88	31.91	30.61
Operating Expense	30.23	30.55	28.26
Net Profit	0.93	0.78	1.54
Net Profit Margin	2.92	2.44	5.03
Earning Per Share	0.08	0.02	0.09
EBIDTA	1.67	1.34	2.47
Effective Tax Rate	19.39	16.91	20.85

Particulars	Sep 2025
Revenue	31.88
Operating Expense	30.23
Net Profit	0.93
Net Profit Margin	2.92
Earning Per Share	0.08
EBIDTA	1.67
Effective Tax Rate	19.39

Ajooni Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	114.69	80.11	74.49
Operating Expenses Annual	111.00	77.88	71.72
Operating Profit Annual	5.76	4.43	3.06
Interest Annual	0.33	0.56	0.48
Depreciation	1.09	0.87	1.00
Net Profit Annual	3.37	2.16	1.12
Tax Annual	0.96	0.83	0.45

Particulars	Mar 2025
Total Revenue Annual	114.69
Operating Expenses Annual	111.00
Operating Profit Annual	5.76
Interest Annual	0.33
Depreciation	1.09
Net Profit Annual	3.37
Tax Annual	0.96

Ajooni Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	0.43	0.31	0.06
Cash Flow from Operations	-17.74	22.91	-5.58
Cash Flow from Investing	-17.14	7.64	-15.82
Cash Flow from Financing	24.83	-3.57	21.66
Cash Flow at the End	-9.62	27.29	0.31

Particulars	Mar 2025
Cash Flow at the Beginning	0.43
Cash Flow from Operations	-17.74
Cash Flow from Investing	-17.14
Cash Flow from Financing	24.83
Cash Flow at the End	-9.62

Ajooni Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	5.01	5.53	4.11
PBIT Margin (%)	4.06	4.44	2.77
PBT Margin (%)	-8.25	-3.47	-2.96
Net PROFIT Margin (%)	2.94	2.70	1.50
Return On Networth / Equity (%)	5.15	5.12	3.86
Return On Networth /Employed (%)	6.89	7.72	5.97
Return On Assets (%)	5.00	4.69	3.26
Total Debt / Equity (X)	0.03	0.09	0.18
Asset Turnover Ratio (%)	1.70	1.74	2.17

Particulars	Mar 2025
PBDIT Margin (%)	5.01
PBIT Margin (%)	4.06
PBT Margin (%)	-8.25
Net PROFIT Margin (%)	2.94
Return On Networth / Equity (%)	5.15
Return On Networth /Employed (%)	6.89
Return On Assets (%)	5.00
Total Debt / Equity (X)	0.03
Asset Turnover Ratio (%)	1.70

Ajooni Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	11.41	10.32	6.29
Total Current Assets Annual	62.00	32.33	34.67
Non Current Assets Annual	33.05	15.19	24.06
Total Shareholders Funds Annual	88.08	42.71	41.67
Total Assets Annual	95.05	47.52	58.73

Particulars	Mar 2025
Fixed Assets Annual	11.41
Total Current Assets Annual	62.00
Non Current Assets Annual	33.05
Total Shareholders Funds Annual	88.08
Total Assets Annual	95.05

Ajooni Biotech Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Ajooni Biotech Ltd Financials

As of Nov 21, 2025, Ajooni Biotech Ltd has a market capitalization of 96.46 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Ajooni Biotech Ltd is with a debt-to-equity ratio of 0.02.

In FY 2024 , Ajooni Biotech Ltd recorded a total revenue of approximately 114.69 Cr marking a significant milestone in the company's financial performance.

Ajooni Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.2% annually, respectively..

Ajooni Biotech Ltd's current PE ratio is 28.62.

Ajooni Biotech Ltd's ROCE averaged 5.8% from the FY ending March 2023 to 2025, with a median of 5.2%. It peaked at 7.9% in March 2024, reflecting strong capital efficiency over the period..

Ajooni Biotech Ltd's latest EBIT is Rs. 4.66 Cr, surpassing the average EBIT of Rs. 3.43 Cr over the 5 years..